DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Gines P, Wong F, Watson H. et al.
Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.
Hepatology 2008;
48: 204-213
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.